Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Gouma

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Vaccine|March 9, 2016
Severity of mumps disease is related to MMR vaccination status and viral sheddingSigrid Gouma, Susan J M Hahné, Daphne B Gijselaar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 SeasonSigrid Gouma, Seth J Zost, Kaela Parkhouse, et al.
Human Vaccines & Immunotherapeutics|June 6, 2015
Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemicPatricia Kaaijk, Sigrid Gouma, Hinke I Hulscher, et al.
Journal of Virology|December 19, 2022
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg AdaptationSigrid Gouma, Colleen Furey, Jefferson J S Santos, et al.
Nature Communications|September 12, 2020
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibilitySigrid Gouma, Kangchon Kim, Madison E Weirick, et al.
Scientific Reports|September 8, 2018
Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteinsSigrid Gouma, Tessa Vermeire, Steven Van Gucht, et al.
Scientific Reports|March 22, 2020
Publisher Correction: Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteinsSigrid Gouma, Tessa Vermeire, Steven Van Gucht, et al.
Vaccine|July 4, 2016
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infectionSigrid Gouma, Hinke I Ten Hulscher, Tessa M Schurink-van 't Klooster, et al.
Obstetrics and Gynecology|June 8, 2022
Neighborhood Characteristics and Racial Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seropositivity in PregnancyHeather H Burris, Anne M Mullin, Miren B Dhudasia, et al.
JAMA Network Open|November 9, 2022
Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 InfectionDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Vaccine|March 9, 2016
Severity of mumps disease is related to MMR vaccination status and viral sheddingSigrid Gouma, Susan J M Hahné, Daphne B Gijselaar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2019
Comparison of Human H3N2 Antibody Responses Elicited by Egg-Based, Cell-Based, and Recombinant Protein-Based Influenza Vaccines During the 2017-2018 SeasonSigrid Gouma, Seth J Zost, Kaela Parkhouse, et al.
Human Vaccines & Immunotherapeutics|June 6, 2015
Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemicPatricia Kaaijk, Sigrid Gouma, Hinke I Hulscher, et al.
Journal of Virology|December 19, 2022
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg AdaptationSigrid Gouma, Colleen Furey, Jefferson J S Santos, et al.
Nature Communications|September 12, 2020
Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibilitySigrid Gouma, Kangchon Kim, Madison E Weirick, et al.
Scientific Reports|September 8, 2018
Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteinsSigrid Gouma, Tessa Vermeire, Steven Van Gucht, et al.
Scientific Reports|March 22, 2020
Publisher Correction: Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteinsSigrid Gouma, Tessa Vermeire, Steven Van Gucht, et al.
Vaccine|July 4, 2016
Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infectionSigrid Gouma, Hinke I Ten Hulscher, Tessa M Schurink-van 't Klooster, et al.
Obstetrics and Gynecology|June 8, 2022
Neighborhood Characteristics and Racial Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seropositivity in PregnancyHeather H Burris, Anne M Mullin, Miren B Dhudasia, et al.
JAMA Network Open|November 9, 2022
Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 InfectionDustin D Flannery, Sigrid Gouma, Miren B Dhudasia, et al.
Pageof 7